Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trial.

Abstract

BACKGROUND The management of hormonal deficiency symptoms in breast cancer survivors is an unsolved problem. While hormone replacement therapy (HRT) may increase the risk of breast cancer in healthy women, its effects on recurrence is unclear. Observational studies have suggested decreased recurrence rates from HRT. The few clinical trials in this field… (More)
DOI: 10.1016/j.ejca.2012.07.003

Topics

Cite this paper

@article{Fahln2013HormoneRT, title={Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trial.}, author={Mia Fahl{\'e}n and Tommy Fornander and Hemming Johansson and Ulla I Johansson and Lars Erik Rutqvist and Nils Wilking and Eva von Schoultz}, journal={European journal of cancer}, year={2013}, volume={49 1}, pages={52-9} }